FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1270-1271 October 26, 2000 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kessler, D. A. Related Article by Tefferi, A.

To the Editor: Post-polycythemic myeloid metaplasia is characterized by increasing splenomegaly, dacryocytes, anemia, extensive bone marrow fibrosis, and a leukoerythroblastic blood picture.¹ We describe a patient with post-polycythemic myeloid metaplasia in whom mucocutaneous myeloid metaplasia developed during treatment with epoetin.

In 1990, myeloid metaplasia developed in a 74-year-old man with a history of polycythemia vera and a history of splenectomy after abdominal trauma. Anemia developed that did not respond to treatment with hydroxyurea, danazol, and epoetin (10,000 U subcutaneously three times a week) and that became transfusion-dependent in December 1994. In December 1997, the patient underwent an abdominal hernia repair . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.